Galactooligosaccharide

Last updated
Galactooligosaccharide
Galactooligosaccharide.svg
Identifiers
ChEBI
Properties
(C6H10O5)n
Molar mass Variable
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Galactooligosaccharides (GOS), also known as oligogalactosyllactose, oligogalactose, oligolactose or transgalactooligosaccharides (TOS), belong to the group of prebiotics. Prebiotics are defined as non-digestible food ingredients that beneficially affect the host by stimulating the growth and/or activity of beneficial bacteria in the colon. GOS occurs in commercially available products such as food for both infants and adults.

Contents

Chemistry

The composition of the galactooligosaccharide fraction varies in chain length and type of linkage between the monomer units. Galactooligosaccharides are produced through the enzymatic conversion of lactose, a component of bovine milk.

A range of factors come into play when determining the yield, style, and type of GOS produced. These factors include:

GOS generally comprise a chain of galactose units that arise through consecutive transgalactosylation reactions, with a terminal glucose unit. However, where a terminal galactose unit is indicated, hydrolysis of GOS formed at an earlier stage in the process has occurred. The degree of polymerization of GOS can vary quite markedly, ranging from 2 to 8 monomeric units, depending mainly on the type of the enzyme used and the conversion degree of lactose.

Digestion research

Because of the configuration of their glycosidic bonds, galactooligosaccharides largely resist hydrolysis by salivary and intestinal digestive enzymes. [1] Galactooligosaccharides are classified as prebiotics, defined as non-digestible food ingredients as substrate for the host by stimulating the growth and activity of bacteria in the colon. [1]

The increased activity of colonic bacteria results in various effects, both directly by the bacteria themselves or indirectly by producing short-chain fatty acids as byproducts via fermentation. Examples of effects are stimulation of immune functions, absorption of essential nutrients, and synthesis of certain vitamins. [2] [3] [4]

Stimulating bacteria

Galactooligosaccharides are a substrate for bacteria, such as Bifidobacteria and lactobacilli. Studies with infants and adults have shown that foods or drinks enriched with galactooligosaccharides result in a significant increase in Bifidobacteria. [1] These sugars can be found naturally in human milk, known as human milk oligosaccharides. [5] Examples include lacto-N-tetraose, lacto-N-neotetraose, and lacto-N-fucopentaose. [6]

Immune response

Human gut microbiota play a key role in the intestinal immune system. [1] Galactooligosaccharides (GOS) support natural defenses of the human body via the gut microflora, [7] indirectly by increasing the number of bacteria in the gut and inhibiting the binding or survival of Escherichia coli, Salmonellatyphimurium and Clostridia. [8] [9] GOS can positively influence the immune system indirectly through the production of antimicrobial substances, reducing the proliferation of pathogenic bacteria. [10] [11]

Constipation

Constipation is a potential problem, particularly among infants, elderly and pregnant women. In infants, formula feeding may be associated with constipation and hard stools. [12] Galactooligosaccharides may improve stool frequency and relieve symptoms related to constipation. [13]

See also

Related Research Articles

<span class="mw-page-title-main">Lactose intolerance</span> Medical condition

Lactose intolerance is a common condition caused by a decreased ability to digest lactose, a sugar found in dairy products. Those affected vary in the amount of lactose they can tolerate before symptoms develop. Symptoms may include abdominal pain, bloating, diarrhea, flatulence, and nausea. These symptoms typically start thirty minutes to two hours after eating or drinking milk-based food. Their severity typically depends on the amount a person eats or drinks. Lactose intolerance does not cause damage to the gastrointestinal tract.

<span class="mw-page-title-main">Dietary fiber</span> Portion of plant-derived food that cannot be completely digested

Dietary fiber or roughage is the portion of plant-derived food that cannot be completely broken down by human digestive enzymes. Dietary fibers are diverse in chemical composition, and can be grouped generally by their solubility, viscosity, and fermentability, which affect how fibers are processed in the body. Dietary fiber has two main components: soluble fiber and insoluble fiber, which are components of plant-based foods, such as legumes, whole grains and cereals, vegetables, fruits, and nuts or seeds. A diet high in regular fiber consumption is generally associated with supporting health and lowering the risk of several diseases. Dietary fiber consists of non-starch polysaccharides and other plant components such as cellulose, resistant starch, resistant dextrins, inulin, lignins, chitins, pectins, beta-glucans, and oligosaccharides.

An oligosaccharide is a saccharide polymer containing a small number of monosaccharides. Oligosaccharides can have many functions including cell recognition and cell adhesion.

Fructooligosaccharides (FOS) also sometimes called oligofructose or oligofructan, are oligosaccharide fructans, used as an alternative sweetener. FOS exhibits sweetness levels between 30 and 50 percent of sugar in commercially prepared syrups. It occurs naturally, and its commercial use emerged in the 1980s in response to consumer demand for healthier and calorie-reduced foods.

<span class="mw-page-title-main">Lactulose</span> Treatment for constipation and hepatic encephalopathy

Lactulose is a non-absorbable sugar used in the treatment of constipation and hepatic encephalopathy. It is used by mouth for constipation and either by mouth or in the rectum for hepatic encephalopathy. It generally begins working after 8–12 hours, but may take up to 2 days to improve constipation.

Prebiotics are compounds in food that induce the growth or activity of beneficial microorganisms such as bacteria and fungi. The most common example is in the gastrointestinal tract, where prebiotics can alter the composition of organisms in the gut microbiome.

A bifidus factor is a compound that specifically enhances the growth of bifidobacteria in either a product or in the intestines of humans and/or animals. Several products have been marketed as bifidogenic factors, such as several prebiotics and methyl-N-acetyl D-glucosamine in human milk.

Natural growth promoters (NGPs) are feed additives for farm animals.

Synbiotics refer to food ingredients or dietary supplements combining probiotics and prebiotics in a form of synergism, hence synbiotics. The synbiotic concept was first introduced as "mixtures of probiotics and prebiotics that beneficially affect the host by improving the survival and implantation of live microbial dietary supplements in the gastrointestinal tract, by selectively stimulating the growth and/or by activating the metabolism of one or a limited number of health-promoting bacteria, thus improving host welfare". As of 2018, the research on this concept is preliminary, with no high-quality evidence from clinical research that such benefits exist.

<i>Bifidobacterium</i> Genus of bacteria

Bifidobacterium is a genus of gram-positive, nonmotile, often branched anaerobic bacteria. They are ubiquitous inhabitants of the gastrointestinal tract though strains have been isolated from the vagina and mouth of mammals, including humans. Bifidobacteria are one of the major genera of bacteria that make up the gastrointestinal tract microbiota in mammals. Some bifidobacteria are used as probiotics.

FODMAPs or fermentable oligosaccharides, disaccharides, monosaccharides, and polyols are short chain carbohydrates that are poorly absorbed in the small intestine and are prone to absorb water and ferment in the colon. They include short chain oligosaccharide polymers of fructose (fructans) and galactooligosaccharides, disaccharides (lactose), monosaccharides (fructose), and sugar alcohols (polyols), such as sorbitol, mannitol, xylitol, and maltitol. Most FODMAPs are naturally present in food and the human diet, but the polyols may be added artificially in commercially prepared foods and beverages.

<span class="mw-page-title-main">Xylooligosaccharide</span> Polymer of the sugar xylose

Xylooligosaccharides (XOS) are polymers of the sugar xylose. They are produced from the xylan fraction in plant fiber. Their C5 structure is fundamentally different from other prebiotics, which are based upon C6 sugars. Xylooligosaccharides have been commercially available since the 1980s, originally produced by Suntory in Japan. They have more recently become more widely available commercially, as technologies have advanced and production costs have fallen. Some enzymes from yeast can exclusively convert xylan into only xylooligosaccharides-DP-3 to 7.

Isomaltooligosaccharide (IMO) is a mixture of short-chain carbohydrates which has a digestion-resistant property. IMO is found naturally in some foods, as well as being manufactured commercially. The raw material used for manufacturing IMO is starch, which is enzymatically converted into a mixture of isomaltooligosaccharides.

Microbiota-accessible carbohydrates (MACs) are carbohydrates that are resistant to digestion by a host's metabolism, and are made available for gut microbes, as prebiotics, to ferment or metabolize into beneficial compounds, such as short chain fatty acids. The term, ‘‘microbiota-accessible carbohydrate’’ contributes to a conceptual framework for investigating and discussing the amount of metabolic activity that a specific food or carbohydrate can contribute to a host's microbiota.

Human milk oligosaccharides (HMOs), also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations in human breast milk. Human milk oligosaccharides promote the development of the immune system, can reduce the pathogen infections and improve brain development and cognition. The HMO profile of human breast milk shapes the gut microbiota of the infant by selectively stimulating bifidobacteria and other bacteria.

<span class="mw-page-title-main">Human milk microbiome</span> Community of microorganisms in human milk

The human milk microbiota, also known as human milk probiotics (HMP), refers to the microbiota residing in the human mammary glands and breast milk. Human breast milk has been traditionally assumed to be sterile, but more recently both microbial culture and culture-independent techniques have confirmed that human milk contains diverse communities of bacteria which are distinct from other microbial communities inhabiting the human body.

<span class="mw-page-title-main">Nutritional immunology</span> Field of immunology

Nutritional immunology is a field of immunology that focuses on studying the influence of nutrition on the immune system and its protective functions. Part of nutritional immunology involves studying the possible effects of diet on the prevention and management on developing autoimmune diseases, chronic diseases, allergy, cancer and infectious diseases. Other related topics of nutritional immunology are: malnutrition, malabsorption and nutritional metabolic disorders including the determination of their immune products.

A low-FODMAP diet is a person's global restriction of consumption of all fermentable carbohydrates (FODMAPs), recommended only for a short time. A low-FODMAP diet is recommended for managing patients with irritable bowel syndrome (IBS) and can reduce digestive symptoms of IBS including bloating and flatulence.

Lacto-<i>N</i>-tetraose Chemical compound

Lacto-N-tetraose is a complex sugar found in human milk. It is one of the few characterized human milk oligosaccharides (HMOs) and is enzymatically synthesized from the substrate lactose. It is biologically relevant in the early development of the infant gut flora.

<span class="mw-page-title-main">Kestose</span> Sugar from fructooligosaccharide group

Kestose is a class of sugars that belongs to a group of fructooligosaccharides.

References

  1. 1 2 3 4 Jeurink, P. V; Van Esch, B. C; Rijnierse, A; Garssen, J; Knippels, LM (2013). "Mechanisms underlying immune effects of dietary oligosaccharides". American Journal of Clinical Nutrition. 98 (2): 572S–7S. doi: 10.3945/ajcn.112.038596 . PMID   23824724.
  2. Gibson GR (October 1998). "Dietary modulation of the human gut microflora using prebiotics". British Journal of Nutrition. 80 (4): S209–12. doi: 10.1017/S0007114500006048 . PMID   9924286.
  3. Roberfroid MB (June 2000). "Prebiotics and probiotics: are they functional foods?". American Journal of Clinical Nutrition. 71 (6 Suppl): 1682S–7S, discussion 1688S–90S. doi: 10.1093/ajcn/71.6.1682S . PMID   10837317.
  4. Macfarlane GT, Steed H, Macfarlane S (February 2008). "Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics". Journal of Applied Microbiology. 104 (2): 305–44. doi:10.1111/j.1365-2672.2007.03520.x. PMID   18215222. S2CID   205319925.
  5. "Human Milk Oligosaccharides". NNI Global Website. Retrieved 2020-12-04.
  6. Miesfeld, Roger L. (July 2017). Biochemistry. McEvoy, Megan M. (First ed.). New York, NY. ISBN   978-0-393-61402-2. OCLC   952277065.
  7. Gibson G.R.; McCartney A.L.; Rastall R.A. (2005). "Prebiotics and resistance to gastrointestinal infections". Br. J. Nutr. 93 (Suppl. 1): 31–34. doi: 10.1079/BJN20041343 . PMID   15877892.
  8. Shoaf K.; Muvey G.L.; Armstrong G.D.; Hutkins R.W. (2006). "Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells". Infect Immun. 74 (12): 6920–8. doi:10.1128/iai.01030-06. PMC   1698067 . PMID   16982832.
  9. Sinclair HR, et al. (2009). "Galactooligosaccharides (GOS) inhibit Vibrio cholerae toxin binding to its GM1 receptor". Journal of Agricultural and Food Chemistry. 57 (8): 3113–3119. doi:10.1021/jf8034786. PMID   19290638.
  10. Macfarlane GT, Steed H, et al. (2008). "Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics". Journal of Applied Microbiology. 104 (2): 305–344. doi:10.1111/j.1365-2672.2007.03520.x. PMID   18215222. S2CID   205319925.
  11. Vos AP, M'Rabet L, et al. (2007). "Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates". Critical Reviews in Immunology . 27 (2): 97–140. doi:10.1615/critrevimmunol.v27.i2.10. PMID   17725499.
  12. Scholtens, P. A; Goossens, D. A; Staiano, A (2014). "Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: A review". World Journal of Gastroenterology. 20 (37): 13446–13452. doi:10.3748/wjg.v20.i37.13446. PMC   4188896 . PMID   25309075.
  13. Yu, T; Zheng, Y. P; Tan, J. C; Xiong, W. J; Wang, Y; Lin, L (2017). "Effects of Prebiotics and Synbiotics on Functional Constipation". The American Journal of the Medical Sciences. 353 (3): 282–292. doi: 10.1016/j.amjms.2016.09.014 . PMID   28262216.